Publication Name	World Journal of Cardiology
Manuscript ID	2830
Country	United States

Received	2013-03-18 09:35
Peer-Review Started	2013-03-20 08:30
To Make the First Decision	2013-04-03 09:14
Return for Revision	2013-04-15 16:24
Revised	2013-04-16 07:47
Second Decision	2013-04-18 16:37
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-04-19 06:12
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-05-23 15:12
Publish the Manuscript Online	2013-05-25 21:15

ISSN	1949-8462 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Editorial
Article Title	Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics
Manuscript Source	Invited Manuscript
All Author List	Wilbert S Aronow
Funding Agency and Grant Number
Corresponding Author	Wilbert S Aronow, MD, FACC, FAHA, Professor of Medicine, Division of Cardiology, Department of Medicine, Westchester Medical Center/New York Medical College, Macy Pavilion, Room 138, Valhalla, NY 10595, United States. wsaronow@aol.com
Key Words	Diabetes mellitus; Blood pressure; Hemoglobin A1c; Serum low-density lipoprotein cholesterol; Statins; Lipid-lowering drugs
Core Tip	2013 guidelines state that a reasonable hemoglobin A1c goal for diabetics is less than 7.0% a hemoglobin A1c level less than 8.0% may be appropriate for patients with a history of severe hypoglycemia, limited life expectancy, advanced macrovascular and microvascular complications, and extensive comorbidities. The systolic blood pressure in most diabetics with hypertension should be reduced to less than 140 mmHg. Diabetics at high risk for cardiovascular events should have their serum low-density lipoprotein (LDL) cholesterol lowered to less than 70 mg/dL with statins. Lower-risk diabetics should have their serum LDL cholesterol reduced to less than 100 mg/dL. Combination therapy of a statin with either a fibrate or niacin is not recommended.
Publish Date	2013-05-25 21:15
Citation	Aronow WS. Editorial on hemoglobin A1c, blood pressure, and low-density lipoprotein cholesterol goals in diabetics. World J Cardiol 2013; 5(5): 119-123
URL	http://www.wjgnet.com/1949-8462/full/v5/i5/119.htm
DOI	http://dx.doi.org/10.4330/wjc.v5.i5.119

Full Article (PDF)	WJC-5-119.pdf
Manuscript File	2830-Review.doc
Answering Reviewers	2830-Answering reviewers.pdf
Copyright License Agreement	2830-Copyright assignment.pdf
Peer-review Report	2830-Peer reviews.pdf
Scientific Editor Work List	2830-Scientific editor work list.doc